期刊
JOURNAL OF HEPATOCELLULAR CARCINOMA
卷 9, 期 -, 页码 1149-1169出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JHC.S382310
关键词
hepatocellular carcinoma; cholangiocarcinoma; immunoenvironment; tertiary lymphoid structures; multiplex immunohistochemistry
类别
Primary liver cancer, including hepatocellular carcinoma and cholangiocarcinoma, is a common and major cause of cancer-related mortality worldwide. Despite advancements in immunotherapies, survival rates for liver cancer remain poor, with limited responses to certain treatments.
One of the most common cancers worldwide, primary liver cancer remains a major cause of cancer-related mortality. Hepatocellular carcinoma and cholangiocarcinoma represent the majority of primary liver cancer cases. Despite advances in the development of novel anti-cancer therapies that exploit targets within the immune system, survival rates from liver cancer remain poor. Furthermore, responses to immunotherapies, such as immune checkpoint inhibitors, have revealed limited and variable responses amongst patients with hepatocellular carcinoma, although combination immunotherapies have shown recent breakthroughs in clinical trials. This has shifted the focus towards improving our understanding of the underlying immune and molecular characteristics of liver tumours that may influence their response to immune-modulating treatments. In this review, we outline the complex interactions that occur in the tumour microenvironment of hepatocellular carcinoma and cholangiocarcinoma, respectively, from a histopathological perspective. We explore the potential role of a classification system based on immune-specific characteristics within each cancer type, the importance of understanding inter-and intra-tumoural heterogeneity and consider the future role of histopathology and novel technologies within this field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据